
Aging is the cause of the loss of vitality on a day-to-day basis, a risk factor for developing chronic diseases and ultimately leading to death. This inevitable biological process is yet to be completely understood. A hypothesis states that manipulation of aging process can enable maintain physiological function and perhaps prevents age related diseases. Currently, model organisms are being used in the investigation of the genetic and molecular mechanism of the aging process. In this study, the adequacy of the major model system, the fruit fly (Drosophila melanogaster) and the rodent mouse (Mus musculus), was analyzed using Jepetto software through comparison of all the genomes of the model organisms with all the genomes of human genome by network statistics of string interactions. The software mapped the gene set of humans and the two model organisms on an interaction network and computed the gene properties by network density, centrality nodes and clustering coefficient. Of all three genomes, the human gene network is the largest and dense with the highest number of neighbors. On the other hand, the mouse and drosophila network are relatively smaller and in terms of density, the former is less dense, and the latter is sparse. The average number of neighbors of both model organisms are similar and approximately 25% of the human network. In the distance/shortest path length between the nodes, there was a decreasing order of connectivity in drosophila to mouse to human. The node with the path length 2 exhibited the highest frequency in all the organisms. In between centrality distribution, the nodes of the human network were observed to be closer. On comparison, mouse network is closer while the drosophila network is widely spread. The information spread between the nodes is measured by the closeness centrality distribution plot and the human network found to have highest closeness centrality than the other two species. Neighborhood connectivity distribution. The network clustering coefficient of genes of drosophila was much more widespread than the other two species.
Background: Oral diseases are thought to produce a negative impact on the quality of life of an individual. It is well-documented now a days that the patient's perception should be familiarized while evaluating oral diseases and the respective treatment measures. Hence, it is imperative to assess the oral health-related quality of life (OHRQoL) that serves to be a vital indicator of the required intervention outcomes in modern-day oral health research and practice. Aim: To assess the OHRQoL among the individuals reporting to the OPD of department of oral pathology& microbiology at Kusum Devi Sunderlal Dugar Jain Dental College & Hospital, Kolkata. Methodology: A cross-sectional study was performed on 600 subjects with age more than 30 years were in good physical and mental health condition. OHIP-14 was used for surveys of 7 dimensions of impact i.e. functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap. Results: The mean age of the patient’s group was 44.57+12.62. Mean OHI-14 score of the surveyed population was 7.095+10.53. There was insignificant difference in mean ohip-14 score among males and females (P= 0.435). Oral health related quality of life was found to have positive correlation with age (R = 0.362; P< 0.0001). Conclusion: Further research with appropriate sample size should be undertaken to emphasize on OHRQoL in the treatment procedure to facilitate in proper planning and evaluating the outcomes that is best suitable for the patient.
Breast cancer has become the most prevalent cancer among all types of cancer in India, and it poses a serious health concern among women. Locally advanced breast cancer (LABC) and advanced breast cancer collectively represent over 70 percent of all cases of breast cancer. In this case report, we presented a 52-year-old female with no significant medical history apart from type II diabetes mellitus who suddenly discovered a lump in her left breast. Initially, the lump was 2 x 1 cm and had progressed to 4 x 3 cm in the left breast. Therefore, she was started with paclitaxel neoadjuvant chemotherapy. Following this, she had undergone left-modified radical mastectomy surgery and was recovering well.
Aim: To evaluate the antidiabetic potential of Putranjiva roxburghii leaves using In vitro models, focusing on their ability to inhibit key enzymes involved in carbohydrate metabolism. Study Design: The current research program is an attempt to screen In vitro anti-diabetic activity of ethanolic extract of Putranjiva roxburghii wall leaves by using – α amylase inhibitory activity and starch iodine assay. Place and Duration of Study: Department of Pharmacology, SJM College of Pharmacy Chitradurga, between July to October. 2024 Methodology: In this study, the crude extract was obtained by using the soxhlet extraction method using 70% ethanol, The extract was used to analyse the antidiabetic activity using in-vitro models namely α-amylase inhibition activity and starch iodine assay, all the experiments were performed in triplicates. The effect of leaf extract was compared with the standard drug metformin. Results: The results of α-amylase inhibition activity showed that the extract inhibits the α amylase enzyme in a concentration (0.3,0.6,0.9,1.2 and 1.5mg/ml) with a percentage inhibition range (6.02%-55.55%) for extract which is not significantly different as compared to metformin (16.12% - 69.89%). Similarly, for starch iodine assay the extract inhibits the α-amylase enzyme in a concentration (same as above) with a percentage inhibition range (16.66%-75%) for extract which is not significantly different as compared to metformin (22.57% - 85.71%). Conclusion: From the above finding of the study, Putranjiva roxburghii wall leaf extract has the ability to inhibit α-amylase enzyme and exhibits antidiabetic activity.
Cerebral malaria is one of the most severe complications of malaria, primarily caused by Plasmodium falciparum. The search for alternative or complementary treatments to classical antimalarial therapies is crucial in light of the emergence of drug resistance. Terminalia superba, a tropical medicinal plant, has traditionally been used to treat various diseases, including those with parasitic etiology. This study aims to evaluate the potential of Terminalia superba in managing cerebral malaria. Ethanolic extracts of T. superba were obtained by maceration of the bark of the plant in 70% alcohol. Cytotoxicity and neuroprotection tests were conducted on neurons (SH-SY5Y-neurons) using the MTT method. The activity against neuroinflammation was assessed through the LPS (Lipopolysaccharide) test, measuring cytokines TNF-α, Interleukin 8, Interleukin 6, and Interleukin 1β. The ethanolic extract of Terminalia superba exhibited non-toxic activity on neurons with an IC50 greater than 200 µg/mL. This extract protected astrocytes against oxidative stress induced by H2O2 (500 µM). Cell survival increased from 35% to 45%, 59%, 61%, and 73% at concentrations of 3.125, 12.5, 50, and 200 µg/mL, respectively. Terminalia superba also reduced the overproduction of cytokines by LPS-stimulated neurons, demonstrating its efficacy against neuroinflammation. The ethanolic extract of Terminalia superba, in addition to being non-cytotoxic, possesses antioxidant and anti-inflammatory properties on neurons. These properties could play an important role in the management of cerebral malaria. Further studies should lead to the development of a drug against cerebral malaria based on the bark of T. superba.